|
|
Article: FDA approves doxycycline tablets, 150 mg.(PIPELINE PREVIEWS)(Mylan Laboratories Inc.)(Brief article)
- Article from:
- Journal of Drugs in Dermatology
- Article date:
- August 1, 2007
- Author:
CopyrightCOPYRIGHT 2007 Journal of Drugs in Dermatology, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Mylan Laboratories Inc recently announced that it has received FDA approval for doxycycline tablets, 150 mg. This medication will be the equivalent generic version of Par Pharmaceutical's doxycycline tablets, 150 mg which are currently marketed by Doak Dermatologics under the brand name Adoxa[R] Tablets. Mylan already has approval and has been marketing doxycycline tablets in 50, 75, and 10 mg strengths.
Marissa Heller MD
Department of Dermatology, Boston University School of Medicine
Pipeline Previews brings you information on the newest ...